Gore and Amphenol Corporation recently launched high-speed interconnect offerings to deliver superior 10 Gigabit Ethernet (GbE) performance for military and civil aircraft applications.

Elixir® Strings announced St. Louis Music as the latest addition to its network of U.S. distributors.

W. L. Gore & Associates, Inc. (Gore) announced the launch of GORE® SYNECOR Biomaterial, a unique hybrid device for hernia repair, at the 17th Annual Hernia Repair Conference held March 30-April 2, 2016 in Washington, D.C.

W. L. Gore & Associates, Inc. (Gore) announced the launch of a new clinical quality improvement project on the newly FDA cleared hernia repair device, GORE® SYNECOR Biomaterial.

W. L. Gore & Associates has been active in the fuel cell industry since the 70s. Now Gore is providing a key component for the groundbreaking Toyota Mirai fuel cell vehicle.

W. L. Gore & Associates, Inc. (Gore) announced the Food and Drug Administration (FDA) approval of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE), making it the first off-the-shelf aortic branch device approved in the United States and the only device indicated for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.

Gore earned the No. 12 spot on the 2016 Fortune 100 Best Companies to Work For® list, announced today.

W. L. Gore & Associates, Inc. (Gore) announced the availability of a new 7.5 centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface.

W. L. Gore & Associates, Inc. (Gore) announced that more than 250,000 patients have been treated with the GORE® EXCLUDER® AAA Endoprosthesis.